LOS ANGELES — Treating nicotine addiction with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) was associated with less weight gain compared with other smoking cessation treatments such as ...
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...
Discontinuing GLP-1 RAs before or during early pregnancy is linked to increased gestational weight gain and pregnancy complications. GLP-1 RAs are not recommended during pregnancy due to potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback